Noninvasive Prenatal Diagnosis Significance of ERG Methylation as a Biomarker in Down's Syndrome

about

Noninvasive Prenatal Diagnosis Significance of ERG Methylation as a Biomarker in Down's Syndrome

Item

http://www.wikidata.org/entity/Q37616062

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 23 January 2017

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Noninvasive Prenatal Diagnosis ...... a Biomarker in Down's Syndrome

@en

Noninvasive Prenatal Diagnosis ...... Biomarker in Down's Syndrome.

@nl

type

Item

label

Noninvasive Prenatal Diagnosis ...... a Biomarker in Down's Syndrome

@en

Noninvasive Prenatal Diagnosis ...... Biomarker in Down's Syndrome.

@nl

prefLabel

Noninvasive Prenatal Diagnosis ...... a Biomarker in Down's Syndrome

@en

Noninvasive Prenatal Diagnosis ...... Biomarker in Down's Syndrome.

@nl

P1476

Noninvasive Prenatal Diagnosis ...... a Biomarker in Down's Syndrome

@en

P2093

Ming Xue

http://www.w3.org/2001/XMLSchema#string

Xiangju Liu

http://www.w3.org/2001/XMLSchema#string

P2860

Human phosphodiesterase 4D7 (PDE4D7) expression is increased in TMPRSS2-ERG-positive primary prostate cancer and independently adds to a reduced risk of post-surgical disease progression

Functional antagonism of TMPRSS2-ERG splice variants in prostate cancer.

ERG oncoprotein inhibits ANXA2 expression and function in prostate cancer

Analytical platform evaluation for quantification of ERG in prostate cancer using protein and mRNA detection methods.

The TMPRSS2:ERG fusion and response to androgen deprivation therapy for prostate cancer

Evaluation of ERG and SPINK1 by Immunohistochemical Staining and Clinicopathological Outcomes in a Multi-Institutional Radical Prostatectomy Cohort of 1067 Patients.

Integrated analysis of DNA methylation and microRNA regulation of the lung adenocarcinoma transcriptome.

hERG potassium channel blockade by the HCN channel inhibitor bradycardic agent ivabradine.

A Prospective Investigation of PTEN Loss and ERG Expression in Lethal Prostate Cancer.

SPOP Promotes Ubiquitination and Degradation of the ERG Oncoprotein to Suppress Prostate Cancer Progression.

P304

398-404

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.12659/MSM.898687

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-01-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28111453

http://www.w3.org/2001/XMLSchema#string

P921

biomarker

P932

5282964

http://www.w3.org/2001/XMLSchema#string